duocarmycin C1,
pyrindamycin B,
6-chloro-2-oxo-1,2-dihydroquinoline-4-carboxylic acid,
6-Chloro-2-hydroxy-quinoline-4-carboxylic acid,
32431-30-4,
118292-35-6,
6-chloro-2-hydroxyquinoline-4-carboxylic acid,
BAS 03230906,
AC1LMN3K,
6-chloro-2-oxo-1H-quinoline-4-carboxylic acid,
AC1Q72Y7,
SCHEMBL7399715,
CTK6H1850,
CTK8F7095,
AMYRRFUUZGORKF-UHFFFAOYSA-N,
ZINC5483246,
0052AD,
SBB011522,
AKOS000300462,
AKOS004910479,
MCULE-2069039052,
NE52556,
RTR-042885,
AJ-54180,
ST50271081,
EN300-72404,
SR-01000368579,
SR-01000368579-1,
Z1172115929,
6-Chloro-2-hydroxy-quinoline-4-carboxylic acid; 6-chloro-2-oxo-1,2-dihydroquinoline-4-carboxylic acid,
Pyrindamycin B,
C10H6ClNO3,
C26-H26-Cl-N3-O8,
CID1133047,
BRN 5689373,
6-Chloro-2-oxo-1,2-dihydroquinoline-4-carboxylicacid,
1H-Pyrrolo[3,2-f]quinoline-2-carboxylic acid, 8-chloro-2,3,6,7,8,9-hexahydro-4-hydroxy-2-methyl-1-oxo-6-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]-, methyl ester, (2R,8S)-,